Frequency of hepatitis B virus-DNA among hepatitis B surface-Ag negative, anti-hepatitis B core antibody-positive blood donors in Yazd, Iran

被引:2
作者
Vaziri, Mahtab [1 ]
Shahshahani, Hayedeh Javadzadeh [2 ]
机构
[1] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Yazd, Iran
[2] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran, Iran
关键词
Anti-hepatitis B core antibody; anti-hepatitis B surface antibody; blood donor; hepatitis B virus-DNA; INFECTION; TRANSFUSION; PREVALENCE; RISK; HBC;
D O I
10.4103/ajts.AJTS_155_18
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The diagnosis of hepatitis B infection in most blood transfusion centers is based on hepatitis B surface (HBs) antigen detection by an enzyme immunoassay method. This study aimed to determine the frequency of hepatitis B core (HBc) antibody, HBs antibody, and hepatitis B virus (HBV) DNA among HBs antigen-negative healthy blood donors of Yazd province, Iran.MATERIALS AND METHODS: This cross-sectional study was conducted on 1500 healthy blood donor samples negative for HBs antigen, hepatitis C virus antibody, human immunodeficiency virus antigen/antibody, and rapid plasma regain tests. All samples were screened for HBc antibody test. HBs antibody and real-time polymerase chain reaction were performed for HBc antibody-positive samples.RESULTS: HBc antibody was positive in 74 (4.9%) samples and 11 (14.9%) of 74 positive samples for HBc antibody were negative for HBs antibody. Sixty-three (85.1%) positive samples for HBc antibody had HBs antibody titer over 10 IU/L, and 43 (58.1%) had HBs antibody titer over 100 IU/L. There was no hepatitis B DNA-positive sample in the present study.CONCLUSIONS: The study results suggest that there is a very low risk for transmission of HBV through blood donors of Yazd, Iran.
引用
收藏
页码:179 / 182
页数:4
相关论文
共 28 条
[1]   Occult Hepatitis B (OBH) in Clinical Settings [J].
Alavian, Seyed Moayed ;
Miri, Seyed Mohammad ;
Hollinger, F. Blaine ;
Jazayeri, Seyed Mohammad .
HEPATITIS MONTHLY, 2012, 12 (08)
[2]  
Alavian SM, 2008, HEPAT MON, V8, P281
[3]  
Amini S, 2004, BLOOD, V5, P67
[4]  
ArabacI F., 2008, Journal of Medical Sciences (Pakistan), V8, P316
[5]  
Ayatollahi Jamshid, 2016, Acta Med Iran, V54, P784
[6]  
Behzad-Behbahani A, 2006, INDIAN J MED RES, V123, P37
[7]   Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice [J].
Bhatti, Farhat Abbas ;
Ullah, Zia ;
Salamat, Nuzhat ;
Ayub, Muhammad ;
Ghani, Ejaz .
TRANSFUSION, 2007, 47 (01) :74-79
[8]   Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico [J].
Calderon, Gloria M. ;
Gonzalez-Velaquez, Felipe ;
Gonzalez-Bonilla, Cesar R. ;
Novelo-Garza, Barbara ;
Terrazas, Jose J. ;
Martinez-Rodriguez, Maria L. ;
Cortes-Marquez, Silvia R. ;
Blanco-Flores, Juan P. ;
Rodriguez-Rodriguez, Arturo ;
Del Campo, Maria A. ;
Cortes-Gomez, Rudy ;
Guadalupe Mejia-Bocanegra, M. .
TRANSFUSION, 2009, 49 (10) :2200-2207
[9]   Transfusion-transmitted hepatitis B virus infection [J].
Candotti, Daniel ;
Allain, Jean-Pierre .
JOURNAL OF HEPATOLOGY, 2009, 51 (04) :798-809
[10]  
Delavari M., 2011, IRAN J BLOOD DISORD, V2, P1